Aaron Horne, MD
Cardiovascular Disease · Livingston, NJNPI 1326208620
Payments from drug & device makers
Across 471 payments — averaging $220.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardiovascular Systems Inc.$45K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$22K
- Edwards Lifesciences$10K
- Pfizer$7K
- Medtronic$5K
- Abbott$3K
- plus $11K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardiovascular Systems Inc. | 65 | $45,321 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 69 | $21,937 |
| Edwards Lifesciences | 28 | $10,216 |
| Pfizer | 6 | $7,103 |
| Medtronic(2 entities) | 63 | $4,928 |
| Abbott | 44 | $3,413 |
| Biotronik Inc. | 33 | $2,946 |
| Bard Peripheral Vascular, Inc. | 13 | $2,354 |
| Philips North America LLC | 15 | $1,191 |
| Boston Scientific | 10 | $754 |
| Acist Medical Systems, Inc. | 10 | $573 |
| Cardiva Medical, Inc. | 19 | $457 |
| AstraZeneca | 14 | $331 |
| Shockwave Medical, Inc | 10 | $310 |
| Novartis | 10 | $306 |
| Penumbra, Inc. | 4 | $296 |
| Abiomed | 5 | $275 |
| Amgen | 16 | $275 |
| Chiesi USA, Inc. | 11 | $165 |
| TEI Biosciences Inc | 1 | $114 |
| Endologix LLC | 1 | $74 |
| Bardy Diagnostics, Inc. | 2 | $59 |
| Livanova USA, Inc. | 1 | $54 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Irhythm Technologies, Inc. | 2 | $30 |
| Novo Nordisk | 2 | $28 |
| Esperion Therapeutics, Inc. | 2 | $28 |
| Merck | 2 | $26 |
| Canon Medical Systems USA, Inc. | 1 | $24 |
| Biosense Webster, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $22 |
| Arbor Pharmaceuticals, Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Surmodics, Inc. | 1 | $21 |
| Cardinal Health 200 LLC | 1 | $14 |
| Baxter Healthcare | 1 | $13 |
| Medicure Pharma Inc. | 1 | $11 |
How this compares
$103,807 in reported general payments places this provider in the 90th percentile of 1,006 cardiovascular disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Livingston
- Bruce HaikLivingston$216K
- Robert KippermanMorristown$5.3M
- Sharan MahalBridgewater$3.5M
- Linda GillamMorristown$2.2M
- Mark GelerntHaddon Heights$2M
- Robert FishbergSpringfield$1.9M
- Dilip ViswanathHaddon Heights$1.8M
- Marc CohenNewark$1M
- Jasjit WaliaElizabeth$859K
- Sajjad SabirCamden$742K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.